Distinguished in Chromosome 18p Deletion

Sabrina Sacconi

Nice, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Chromosome 18p Deletion
Nice, FR 
OverviewLocationsClinical Research

Overview

Sabrina Sacconi practices in Nice, France. Ms. Sacconi is rated as a Distinguished expert by MediFind in the treatment of Chromosome 18p Deletion. Her top areas of expertise are Facioscapulohumeral Muscular Dystrophy (FSHD), Pompe Disease, Myasthenia Gravis, and Chromosome 18p Deletion.

Her clinical research consists of co-authoring 137 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Chromosome 18p Deletion.

Gender
Female

Locations

Nice, France
Other Locations
Lille, France
Marseille, France
France
660 Route Des Lucioles, Valbonne, France
CNRS UMR 7284, INSERM U1081, 30, Avenue De La Voie Romaine, Romaine, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Study of Predictive Factors of Progression of Motor Neurone Disease Prognosis and Endophenotype Biomarkers French Database Set up
Study of Predictive Factors of Progression of Motor Neurone Disease Prognosis and Endophenotype Biomarkers French Database Set up
Enrollment Status: Recruiting
Publish Date: November 07, 2022
Intervention Type: Other
Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI Study
Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI Study
Enrollment Status: Completed
Publish Date: September 30, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Multicenter, Interventional, Open-label Study to Monitor the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA®
A Multicenter, Interventional, Open-label Study to Monitor the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA®
Enrollment Status: Completed
Publish Date: September 20, 2024
Intervention Type: Other
Study Phase: Not Applicable
Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Enrollment Status: Completed
Publish Date: August 28, 2024
Intervention Type: Biological
Study Drug: HYQVIA
Study Phase: Phase 3
Effect of Psyllium (Plantago Ovata) on Digestive Disorders in Familial Amyloidosis
Effect of Psyllium (Plantago Ovata) on Digestive Disorders in Familial Amyloidosis
Enrollment Status: Withdrawn
Publish Date: November 18, 2023
Intervention Type: Dietary supplement
Study Phase: Not Applicable
Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2
Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Biological
Study Phase: Not Applicable
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Biological
Study Drugs: HYQVIA, Intravenous Immunoglobulin G
Study Phase: Phase 3
Frequency of Pompe's Disease and Neuromuscular Etiologies in Patients With Restrictive Respiratory Failure Associated With Signs of Muscle Weakness
Frequency of Pompe's Disease and Neuromuscular Etiologies in Patients With Restrictive Respiratory Failure Associated With Signs of Muscle Weakness
Enrollment Status: Completed
Publish Date: March 22, 2023
Intervention Type: Other
Study Phase: Not Applicable
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials

137 Total Publications

Nitrous Oxide-Associated Myelopolyneuropathy-A Case Series.
Nitrous Oxide-Associated Myelopolyneuropathy-A Case Series.
Journal: Journal of clinical neuromuscular disease
Published: September 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sacconi's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 33 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile